"Methods And Compositions For Treating Neurodegenerative Diseases" in Patent Application Approval Process (USPTO 20240100076).
In: Drug Week, 2024-04-16, S. 3346-3346
serialPeriodical
Zugriff:
A patent application has been filed for methods and compositions to treat neurodegenerative diseases. Neurological diseases, such as Alzheimer's and Parkinson's, are difficult to treat, and there are currently no effective drugs available. The inventors propose using gangliosides, specifically GD3 and GM1, delivered intranasally or through other routes, to prevent, inhibit, or treat neurodegenerative diseases. These gangliosides have shown promising results in restoring neural stem cell function, increasing neurogenesis, and removing neurotoxic proteins. The methods described in the patent application offer potential treatment options for various neurologic disorders. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Methods And Compositions For Treating Neurodegenerative Diseases" in Patent Application Approval Process (USPTO 20240100076).
|
---|---|
Zeitschrift: | Drug Week, 2024-04-16, S. 3346-3346 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Schlagwort: |
|
Sonstiges: |
|